Linked Life Data

20179914

Source:http://linkedlifedata.com/resource/pubmed/id/20179914

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2010-4-13
pubmed:abstractText
This study aimed to investigate the effect of rifampicin, an inducer of CYP3A4 and P-glycoprotein, on the pharmacokinetics and pharmacodynamics of aliskiren, a renin inhibitor used in the treatment of hypertension.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1432-1041
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
66
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
497-502
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Rifampicin reduces the plasma concentrations and the renin-inhibiting effect of aliskiren.
pubmed:affiliation
Department of Clinical Pharmacology, University of Helsinki, Helsinki, Finland.
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't